Raleigh Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,070
Closed -$5.25K 1104
2023
Q4
$5.25K Buy
1,070
+240
+29% +$1.18K ﹤0.01% 728
2023
Q3
$4.52K Buy
830
+140
+20% +$1.12K ﹤0.01% 699
2023
Q2
$6.39K Buy
690
+30
+5% +$254 ﹤0.01% 590
2023
Q1
$5.42K Sell
660
-80
-11% -$883 ﹤0.01% 601
2022
Q4
$8.24K Buy
740
+30
+4% +$349 ﹤0.01% 472
2022
Q3
$8K Hold
710
﹤0.01% 409
2022
Q2
$11K Buy
710
+60
+9% +$1.08K 0.01% 333
2022
Q1
$14K Buy
+650
New +$14K 0.01% 326

Other funds holding MPT

Raleigh Capital Management's MPT Position: Q1 2024 in Review

Raleigh Capital Management sold out of Medical Properties Trust (MPT) in Q1 2024, closing a stake of 1,070 shares — an estimated $5.25K sold.

Raleigh Capital Management first reported a position in MPT in Q1 2022 and held it in 8 quarters. The position peaked at $14K in Q1 2022. 510 funds tracked by Wall St. Rank hold MPT as of Q1 2024.

  • Raleigh Capital Management reported no remaining Medical Properties Trust position as of Q1 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 1,070 Medical Properties Trust shares in Q1 2024, an estimated $5.25K.
  • Raleigh Capital Management first reported a position in Medical Properties Trust in Q1 2022 and held it in 8 quarters.
  • Raleigh Capital Management's Medical Properties Trust position peaked at $14K in Q1 2022.
  • 510 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.